Undifferentiated sarcoma is a rare and aggressive type of cancer that develops in the soft tissues of the body, affecting fewer than 5,000 people in the United States each year. While its exact causes remain unclear, this challenging disease requires swift diagnosis and comprehensive treatment involving surgery, radiation, and sometimes other therapies to help patients manage this serious condition.
Understanding Undifferentiated Sarcoma
Undifferentiated sarcoma refers to a group of cancers that begin in the body’s connective tissues. These tissues include muscles, fat, fibrous tissue, blood vessels, nerves, and other supportive structures that connect and support organs throughout the body. The name “undifferentiated” comes from how these cancer cells appear under a microscope—they don’t look like the normal body tissues where they develop, making them difficult to classify into specific categories.[1]
When doctors examine these cancer cells, they notice something called pleomorphism, which means the cells grow in multiple shapes and sizes rather than having a uniform appearance. This disorganized growth pattern is one of the key characteristics that helps identify this type of cancer. The cells vary not only in their overall size and shape but also in their nuclei, which are the structures inside cells that contain genetic material.[2]
Undifferentiated sarcoma was previously known as malignant fibrous histiocytoma. Researchers originally thought this cancer formed in specialized immune cells called histiocytes, but later studies suggested it more likely starts in mesenchymal cells, which are primitive cells that form connective tissue. This change in understanding led to the current name, which better reflects what scientists know about the disease today.[2]
This cancer is considered a diagnosis of exclusion, meaning doctors arrive at this conclusion after ruling out other specific types of sarcoma. During examination, if the tissue sample doesn’t show characteristics of any particular sarcoma subtype, it receives the classification of undifferentiated sarcoma.[3]
Where Undifferentiated Sarcoma Develops
Undifferentiated sarcoma most commonly develops in the deep soft tissues of the arms and legs, with the thigh being an especially frequent location. However, this cancer can appear virtually anywhere in the body. It can also develop in the trunk or in the retroperitoneum, which is the area behind the organs in the abdomen. In rare cases, undifferentiated sarcoma can even affect bones, though this occurs much less frequently than soft tissue involvement.[4]
When this cancer occurs in the abdomen, it may press on nearby organs like the intestines, potentially causing constipation or other digestive problems. If it develops in the chest area near the lungs, it might cause breathing difficulties. In the limbs, a growing tumor can compress nerves, leading to unusual sensations like numbness, tingling, or muscle weakness in the affected area.[3]
How Common Is Undifferentiated Sarcoma
Undifferentiated sarcoma is quite rare overall, affecting fewer than 5,000 people in the United States annually. However, despite being uncommon in the general population, it represents one of the three most frequently occurring soft tissue sarcomas in adults, along with liposarcoma and leiomyosarcoma. Together, undifferentiated sarcomas account for approximately 5% to 10% of all soft tissue sarcoma cases.[4]
The disease can occur at any age, but it tends to affect older adults more frequently. It is particularly common in people over the age of 50, and while undifferentiated sarcoma can occur in children and younger adults, the pleomorphic form predominantly appears in the older population. The condition affects both males and females, though white males appear to have the highest risk of developing this type of cancer.[2]
Because undifferentiated sarcomas can include different subtypes—such as spindle cell, pleomorphic, and round cell varieties—they may account for as many as 20% of all soft tissue sarcomas when considered as a group. The round cell type tends to appear more frequently in younger patients, while the pleomorphic type is more common in older adults.[7]
What Causes Undifferentiated Sarcoma
The exact causes of undifferentiated sarcoma remain unclear to medical researchers. What scientists do understand is that this cancer begins when healthy cells develop changes in their DNA. These genetic changes contain the instructions that tell cells how to function, and when alterations occur, they can cause cells to multiply rapidly and form abnormal masses called tumors. However, researchers haven’t yet identified what triggers these DNA changes in the first place.[6]
The abnormal cells in undifferentiated sarcoma can invade and destroy healthy tissue nearby. Over time, some of these cancer cells can break away from the original tumor and spread to other parts of the body through a process called metastasis. The lungs are the most common site for this spread to occur, though cancer cells can also travel to lymph nodes, bones, and the liver.[4]
Unlike some other types of cancer that have clear genetic markers or consistent chromosomal patterns, undifferentiated sarcomas display highly complex and varied genetic abnormalities. Studies using advanced genetic testing have revealed that these tumors have extensive genomic rearrangements, meaning the chromosomes are severely mixed up and altered. This complexity makes it difficult to identify specific genes or pathways that could be targeted with medication.[7]
Risk Factors for Developing Undifferentiated Sarcoma
Several factors can increase a person’s chances of developing undifferentiated sarcoma, though it’s important to note that most people who develop this cancer don’t have any known risk factors. Understanding these risk factors helps doctors identify patients who may benefit from closer monitoring, but having one or more risk factors doesn’t mean a person will definitely develop the disease.[2]
Age plays a significant role, with people over 50 years old facing higher risk compared to younger individuals. Gender also matters, as males develop undifferentiated sarcoma more frequently than females, with white males showing the highest rates of occurrence. This gender difference persists across different age groups and geographic locations.[2]
Certain pre-existing medical conditions increase vulnerability to undifferentiated sarcoma. People with neurofibromatosis, a genetic disorder that causes tumors to grow on nerves, face elevated risk. Similarly, individuals with Paget’s disease of bone, a condition that disrupts normal bone replacement processes, have higher likelihood of developing this cancer. Genetic disorders like Li-Fraumeni syndrome, which is associated with increased cancer risk in general, also predispose people to sarcomas.[6]
Environmental and occupational exposures contribute to risk as well. Previous radiation therapy to an area of the body significantly increases the chance that sarcoma will develop there later. This risk applies whether the radiation was used to treat a previous cancer or for other medical reasons. Workers with occupational exposure to radiation also face increased risk. Exposure to certain chemicals, including arsenic and vinyl chloride, has been linked to higher rates of undifferentiated sarcoma development.[2]
The etiology of most undifferentiated sarcomas remains unknown, but radiation association is particularly significant—studies show that at least 25% of radiation-associated soft tissue sarcomas are undifferentiated types. This suggests that radiation damage to cells may be particularly likely to result in this form of cancer when malignancy does occur.[7]
Recognizing the Symptoms
The symptoms of undifferentiated sarcoma vary considerably depending on where the cancer develops in the body, and in many cases, the disease doesn’t cause obvious warning signs in its early stages. This lack of clear symptoms can delay diagnosis, which is concerning given the aggressive nature of this cancer. Understanding potential symptoms helps patients and doctors identify the disease earlier.[1]
The most common symptom is a growing lump or area of swelling. In many cases, this lump is painless, which can make people less likely to seek medical attention. The mass may or may not move when touched, and typically there are no visible skin changes on the surface. If the lump grows very large, it may eventually cause pain, tingling sensations, or numbness in the surrounding area as it presses against nerves or other structures.[2]
When undifferentiated sarcoma occurs in an arm or leg, patients might notice swelling in the hand or foot of the affected limb. This happens because the growing tumor can interfere with normal blood flow or lymphatic drainage. Some people experience numbness or tingling if the lump is pushing on a nerve or if the tumor itself arises from nerve tissue. Muscle weakness can develop if nerves that control muscles become compressed.[1]
Sarcomas that develop in the abdomen present different symptoms. Patients might experience abdominal pain, loss of appetite, or constipation as the tumor presses on the intestines or other digestive organs. The mass can grow quite large before causing noticeable symptoms because there’s more space in the abdomen for expansion compared to the limbs.[1]
Some patients experience general symptoms that aren’t specific to sarcoma but indicate that something is wrong in the body. These include unexplained fever, unintended weight loss, and a general feeling of being unwell. However, it’s important to note that undifferentiated sarcoma doesn’t typically cause symptoms like fever, weight loss, or general malaise, especially in early stages. These symptoms are more likely to appear if the cancer is advanced or has spread.[2]
The rapid growth rate is another characteristic feature. Unlike benign lumps that grow slowly or remain stable over months and years, undifferentiated sarcomas often increase in size relatively quickly. This progressive enlargement is an important warning sign that medical evaluation is needed.[7]
Preventing Undifferentiated Sarcoma
Because the causes of undifferentiated sarcoma aren’t well understood, there are no proven prevention strategies that can guarantee avoiding the disease. However, understanding risk factors helps people make informed decisions about their health and seek appropriate medical care when needed.[6]
For people who require radiation therapy as part of cancer treatment or for other medical conditions, the benefits of radiation typically far outweigh the small increased risk of developing sarcoma years later. However, patients should discuss with their doctors the long-term risks of any treatment plan and ensure that radiation is used only when medically necessary and at appropriate doses. Following radiation treatment, being vigilant about monitoring the treated area for any unusual lumps or changes is important.[7]
Workplace safety measures are crucial for people whose jobs involve potential exposure to radiation or hazardous chemicals like arsenic and vinyl chloride. Following proper safety protocols, using protective equipment, and adhering to exposure limits can help reduce risk. Regular health screenings for workers in high-risk occupations may help detect problems early.[2]
People with genetic conditions that increase cancer risk, such as Li-Fraumeni syndrome or neurofibromatosis, should work closely with their healthcare team to develop appropriate monitoring plans. While these individuals can’t change their genetic makeup, increased surveillance may help detect cancers earlier when they’re more treatable. Genetic counseling can help affected individuals and their families understand risks and make informed decisions about screening.[6]
For everyone, being aware of changes in your body is important. Any new lump, especially one that grows over time, should be evaluated by a doctor. While most lumps aren’t cancer, persistent or growing masses deserve medical attention. Don’t wait to see if a lump will go away on its own, particularly if it’s accompanied by other symptoms like pain, numbness, or functional limitations.[1]
How the Disease Affects the Body
Undifferentiated sarcoma disrupts normal body function in several ways. At the cellular level, the disease begins when primitive mesenchymal cells that normally form healthy connective tissue undergo changes that prevent proper differentiation. Instead of developing into specialized cells that serve specific purposes, these cells remain undifferentiated and multiply uncontrollably, forming a mass of abnormal tissue.[4]
The tumor cells in undifferentiated sarcoma are characterized by marked cellular pleomorphism, meaning they display extreme variations in size, shape, and appearance. When pathologists examine these cells under a microscope, they observe atypical mitotic figures—abnormal patterns of cell division that indicate rapid and disorganized growth. Areas of necrosis, where tissue has died, often appear within the tumor because the cancer cells grow so quickly that they outpace their blood supply.[4]
As the tumor grows, it invades surrounding healthy tissue. Unlike benign growths that typically remain contained within a capsule, malignant sarcomas infiltrate adjacent structures. This invasive growth can damage muscles, compress blood vessels, and press against nerves, disrupting normal function in the affected area. The mechanical pressure from a large tumor can impair circulation, cause swelling, and interfere with the normal movement and sensation of limbs.[3]
Undifferentiated sarcoma is considered an aggressive malignancy with a high propensity for both local recurrence and distant metastasis. Local recurrence means the cancer can grow back in or near the same place even after treatment removes it. Distant metastasis occurs when cancer cells break away from the primary tumor and travel through the bloodstream or lymphatic system to establish new tumors elsewhere in the body. The lungs are the most frequent site of metastasis, though the cancer can also spread to lymph nodes, bones, and liver.[4]
The genetic complexity of undifferentiated sarcoma contributes to its aggressive behavior. These tumors typically display extensive genomic rearrangements, with chromosome numbers ranging from abnormally low to extremely high. Whole-genome studies reveal structural rearrangements and copy-number changes involving most or all chromosomes. Some tumors undergo dramatic genetic events like whole-genome duplications or chromothripsis, where chromosomes shatter and reassemble incorrectly. These widespread genetic changes make the cancer cells unstable and difficult to control with targeted therapies.[7]



